Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wülfing Pharma is a German pharmaceutical company and contract manufacturer based in Gronau, specializing in the production of solid, liquid, and semi-solid dosage forms. Founded in the early 20th century, the company has a long history in the development and marketing of established medicines, notably in the cardiovascular field. In 2004, the company was acquired by Dermapharm Holding SE, becoming a core manufacturing and logistics hub for the group. The company operates a state-of-the-art, GMP-certified facility that provides comprehensive contract manufacturing (CMO) services to international pharmaceutical partners. Their capabilities include high-volume tablet production, specialized film coating, and the filling of liquids and ointments. Wülfing Pharma maintains a strong presence in the European market, leveraging its integrated supply chain to distribute both proprietary and third-party healthcare products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wulfing Pharma.